United States Biotechnology & Medical Research

Rubius Therapeutics Inc (RUBY)

Track

Track

Ticker: RUBY Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Rubius Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.7
Appelhans Dannielle CEO and President Officer
Transaction date
Sale
Price
261.21
Quantity 37,882 +36.7%
Value US$235,626
2.3
CAGNONI PABLO J Non-Executive Director
Transaction date
Sale
Price
211.76
Quantity 80,663 +48.5%
Value US$4,587,520
3.7
Appelhans Dannielle CEO and President Officer
Transaction date
Sale
Price
287.89
Quantity 72,139 +32.7%
Value US$4,171,071
Turka Laurence A. Chief Scientific Officer Officer
Transaction date
Sale
Price
0.24
Quantity 2,593 -12.4%
Value US$622
2.3
CAGNONI PABLO J Non-Executive Director
Transaction date
Sale
Price
0.24
Quantity 7,240 -8.9%
Value US$1,745
3.7
Appelhans Dannielle Chief Operating Officer Officer
Transaction date
Sale
Price
0.80
Quantity 5,737 -45.9%
Value US$4,590
2.1
Epstein David R Non-Executive Director
Transaction date
Purchase
Price
1.44
Quantity 30,000 +0.6%
Value US$43,329
Turka Laurence A. Chief Scientific Officer Officer
Transaction date
Sale
Price
6.57
Quantity 2,517 -33.8%
Value US$16,544
2.3
CAGNONI PABLO J CEO and President Executive Director
Transaction date
Sale
Price
6.57
Quantity 6,730 -15.9%
Value US$44,236
Keson-Brookes Maiken CLO & Corp. Secretary Officer
Transaction date
Sale
Price
6.57
Quantity 2,732 -33.8%
Value US$17,957
Keson-Brookes Maiken CLO & Corp. Secretary Officer
Transaction date
Planned sale
Price
20.24
Quantity 25,000 -100.0%
Value US$505,965
2.1
Epstein David R Non-Executive Director
Transaction date
Planned sale
Price
14.93
Quantity 26,704 -0.6%
Value US$398,560
2.1
Epstein David R Non-Executive Director
Transaction date
Planned sale
Price
14.79
Quantity 7,404 -0.2%
Value US$109,525
2.1
Epstein David R Non-Executive Director
Transaction date
Planned sale
Price
14.83
Quantity 2,100 -0.0%
Value US$31,146
2.1
Epstein David R Non-Executive Director
Transaction date
Planned sale
Price
14.88
Quantity 89,233 -1.9%
Value US$1,328,117
2.3
Coughlin Christina M. Chief Medical Officer Officer
Transaction date
Purchase
Price
5.52
Quantity 19,000 +inf%
Value US$104,814
2.3
CAGNONI PABLO J CEO and President Executive Director
Transaction date
Purchase
Price
4.70
Quantity 21,000 +inf%
Value US$98,694
2.1
Epstein David R Non-Executive Director
Transaction date
Purchase
Price
3.76
Quantity 5,000 +0.1%
Value US$18,800
2.1
Epstein David R Non-Executive Director
Transaction date
Purchase
Price
4.00
Quantity 5,000 +0.1%
Value US$20,000
2.1
Epstein David R Non-Executive Director
Transaction date
Purchase
Price
3.82
Quantity 5,000 +0.1%
Value US$19,100
CARPENTER CHRISTOPHER L. Chief Medical Officer Officer
Transaction date
Planned sale
Price
13.48
Quantity 48,000 -57.9%
Value US$646,901
LANGER ROBERT
Transaction date
Planned sale
Price
8.52
Quantity 7,500 -100.0%
Value US$63,874
CARPENTER CHRISTOPHER L. Chief Medical Officer
Transaction date
Planned sale
Price
10.05
Quantity 11,877 -25.4%
Value US$119,309
CARPENTER CHRISTOPHER L. Chief Medical Officer
Transaction date
Planned sale
Price
10.13
Quantity 36,123 -50.9%
Value US$365,897
LANGER ROBERT
Transaction date
Planned sale
Price
14.94
Quantity 7,500 -100.0%
Value US$112,048
CARPENTER CHRISTOPHER L. Chief Medical Officer
Transaction date
Planned sale
Price
13.93
Quantity 243 -0.7%
Value US$3,386
CARPENTER CHRISTOPHER L. Chief Medical Officer
Transaction date
Planned sale
Price
13.80
Quantity 18,399 -34.6%
Value US$253,868
CARPENTER CHRISTOPHER L. Chief Medical Officer
Transaction date
Planned sale
Price
14.27
Quantity 10,858 -23.8%
Value US$154,958
CARPENTER CHRISTOPHER L. Chief Medical Officer
Transaction date
Planned sale
Price
14.10
Quantity 18,500 -34.7%
Value US$260,868
LANGER ROBERT
Transaction date
Planned sale
Price
17.57
Quantity 7,500 -100.0%
Value US$131,799
NISSEN TORBEN STRAIGHT President
Transaction date
Planned sale
Price
20.00
Quantity 12,096 -0.7%
Value US$241,920
CARPENTER CHRISTOPHER L. Chief Medical Officer
Transaction date
Planned sale
Price
15.84
Quantity 48,000 -57.9%
Value US$760,114
LANGER ROBERT Non-Executive Director
Transaction date
Planned sale
Price
14.59
Quantity 7,500 -100.0%
Value US$109,444
Pomerantz Roger Non-Executive Director
Transaction date
Purchase
Price
23.00
Quantity 100 +inf%
Value US$2,300
Sohn Catherine A. Non-Executive Director
Transaction date
Purchase
Price
23.00
Quantity 2,500 +inf%
Value US$57,500
Symonds Jonathan Non-Executive Director
Transaction date
Purchase
Price
23.00
Quantity 25,000 +inf%
Value US$575,000
Cuss Francis M Non-Executive Director
Transaction date
Purchase
Price
23.00
Quantity 10,000 +inf%
Value US$230,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-02-27 2023-02-24 S Sale
3.7
Appelhans Dannielle

CEO and President

Officer
37,882 +36.7%
261.21
US$235,626 		37,882 +36.7% 261.21 US$235,626
2023-02-01 2023-02-01 S Sale
2.3
CAGNONI PABLO J
Non-Executive Director
80,663 +48.5%
211.76
US$4,587,520 		80,663 +48.5% 211.76 US$4,587,520
2023-02-01 2023-02-01 S Sale
3.7
Appelhans Dannielle

CEO and President

Officer
72,139 +32.7%
287.89
US$4,171,071 		72,139 +32.7% 287.89 US$4,171,071
2023-01-31 2023-01-31 S Sale
Turka Laurence A.

Chief Scientific Officer

Officer
2,593 -12.4%
0.24
US$622 		2,593 -12.4% 0.24 US$622
2023-01-31 2023-01-31 S Sale
2.3
CAGNONI PABLO J
Non-Executive Director
7,240 -8.9%
0.24
US$1,745 		7,240 -8.9% 0.24 US$1,745
2022-08-12 2022-08-10 S Sale
3.7
Appelhans Dannielle

Chief Operating Officer

Officer
5,737 -45.9%
0.80
US$4,590 		5,737 -45.9% 0.80 US$4,590
2022-04-22 2022-04-21 B Purchase
2.1
Epstein David R
Non-Executive Director
30,000 +0.6%
1.44
US$43,329 		30,000 +0.6% 1.44 US$43,329
2022-02-01 2022-02-01 S Sale
Turka Laurence A.

Chief Scientific Officer

Officer
2,517 -33.8%
6.57
US$16,544 		2,517 -33.8% 6.57 US$16,544
2022-02-01 2022-02-01 S Sale
2.3
CAGNONI PABLO J

CEO and President

Executive Director
6,730 -15.9%
6.57
US$44,236 		6,730 -15.9% 6.57 US$44,236
2022-02-01 2022-02-01 S Sale
Keson-Brookes Maiken

CLO & Corp. Secretary

Officer
2,732 -33.8%
6.57
US$17,957 		2,732 -33.8% 6.57 US$17,957
2021-03-23 2021-03-19 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
70,000 +2.7%
29.00
US$2,030,000 		70,000 +2.7% 29.00 US$2,030,000
2021-03-23 2021-03-19 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
70,000 +1.2%
29.00
US$2,030,000 		70,000 +1.2% 29.00 US$2,030,000
2021-03-23 2021-03-19 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
70,000 +0.5%
29.00
US$2,030,000 		70,000 +0.5% 29.00 US$2,030,000
2021-03-15 2021-03-15 PlS Planned sale
Keson-Brookes Maiken

CLO & Corp. Secretary

Officer
25,000 -100.0%
20.24
US$505,965 		25,000 -100.0% 20.24 US$505,965
2021-02-16 2021-02-11 PlS Planned sale
2.1
Epstein David R
Non-Executive Director
26,704 -0.6%
14.93
US$398,560 		26,704 -0.6% 14.93 US$398,560
2021-02-10 2021-02-10 PlS Planned sale
2.1
Epstein David R
Non-Executive Director
7,404 -0.2%
14.79
US$109,525 		7,404 -0.2% 14.79 US$109,525
2021-02-10 2021-02-09 PlS Planned sale
2.1
Epstein David R
Non-Executive Director
2,100 -0.0%
14.83
US$31,146 		2,100 -0.0% 14.83 US$31,146
2021-02-10 2021-02-08 PlS Planned sale
2.1
Epstein David R
Non-Executive Director
89,233 -1.9%
14.88
US$1,328,117 		89,233 -1.9% 14.88 US$1,328,117
2020-04-24 2020-04-22 B Purchase
2.3
Coughlin Christina M.

Chief Medical Officer

Officer
19,000 +inf%
5.52
US$104,814 		19,000 +inf% 5.52 US$104,814
2020-04-15 2020-04-14 B Purchase
2.3
CAGNONI PABLO J

CEO and President

Executive Director
21,000 +inf%
4.70
US$98,694 		21,000 +inf% 4.70 US$98,694
2020-03-19 2020-03-17 B Purchase
2.1
Epstein David R
Non-Executive Director
5,000 +0.1%
3.76
US$18,800 		5,000 +0.1% 3.76 US$18,800
2020-03-17 2020-03-13 B Purchase
2.1
Epstein David R
Non-Executive Director
5,000 +0.1%
4.00
US$20,000 		5,000 +0.1% 4.00 US$20,000
2020-03-17 2020-03-13 B Purchase
2.1
Epstein David R
Non-Executive Director
5,000 +0.1%
3.82
US$19,100 		5,000 +0.1% 3.82 US$19,100
2019-12-18 2019-12-16 PlS Planned sale CARPENTER CHRISTOPHER L.

Chief Medical Officer

Officer
48,000 -57.9%
13.48
US$646,901 		48,000 -57.9% 13.48 US$646,901
2019-10-17 2019-10-14 PlS Planned sale
LANGER ROBERT
7,500 -100.0%
8.52
US$63,874 		7,500 -100.0% 8.52 US$63,874
2019-09-18 2019-09-17 PlS Planned sale
CARPENTER CHRISTOPHER L.

Chief Medical Officer
11,877 -25.4%
10.05
US$119,309 		11,877 -25.4% 10.05 US$119,309
2019-09-18 2019-09-16 PlS Planned sale
CARPENTER CHRISTOPHER L.

Chief Medical Officer
36,123 -50.9%
10.13
US$365,897 		36,123 -50.9% 10.13 US$365,897
2019-07-17 2019-07-15 PlS Planned sale
LANGER ROBERT
7,500 -100.0%
14.94
US$112,048 		7,500 -100.0% 14.94 US$112,048
2019-06-24 2019-06-20 PlS Planned sale
CARPENTER CHRISTOPHER L.

Chief Medical Officer
243 -0.7%
13.93
US$3,386 		243 -0.7% 13.93 US$3,386
2019-06-19 2019-06-19 PlS Planned sale
CARPENTER CHRISTOPHER L.

Chief Medical Officer
18,399 -34.6%
13.80
US$253,868 		18,399 -34.6% 13.80 US$253,868
2019-06-19 2019-06-18 PlS Planned sale
CARPENTER CHRISTOPHER L.

Chief Medical Officer
10,858 -23.8%
14.27
US$154,958 		10,858 -23.8% 14.27 US$154,958
2019-06-19 2019-06-17 PlS Planned sale
CARPENTER CHRISTOPHER L.

Chief Medical Officer
18,500 -34.7%
14.10
US$260,868 		18,500 -34.7% 14.10 US$260,868
2019-04-17 2019-04-15 PlS Planned sale
LANGER ROBERT
7,500 -100.0%
17.57
US$131,799 		7,500 -100.0% 17.57 US$131,799
2019-04-10 2019-04-08 PlS Planned sale
NISSEN TORBEN STRAIGHT

President
2,100 -0.1%
20.00
US$42,000 		2,100 -0.1% 20.00 US$42,000
2019-04-05 2019-04-05 PlS Planned sale
NISSEN TORBEN STRAIGHT

President
12,096 -0.7%
20.00
US$241,920 		12,096 -0.7% 20.00 US$241,920
2019-04-05 2019-04-03 PlS Planned sale
NISSEN TORBEN STRAIGHT

President
500 -0.0%
20.00
US$10,000 		500 -0.0% 20.00 US$10,000
2019-03-19 2019-03-15 PlS Planned sale
CARPENTER CHRISTOPHER L.

Chief Medical Officer
48,000 -57.9%
15.84
US$760,114 		48,000 -57.9% 15.84 US$760,114
2019-01-18 2019-01-14 PlS Planned sale
LANGER ROBERT
Non-Executive Director
7,500 -100.0%
14.59
US$109,444 		7,500 -100.0% 14.59 US$109,444
2018-07-23 2018-07-20 B Purchase Pomerantz Roger Non-Executive Director
100 +inf%
23.00
US$2,300 		100 +inf% 23.00 US$2,300
2018-07-23 2018-07-20 B Purchase Sohn Catherine A. Non-Executive Director
2,500 +inf%
23.00
US$57,500 		2,500 +inf% 23.00 US$57,500
2018-07-23 2018-07-20 B Purchase Symonds Jonathan Non-Executive Director
25,000 +inf%
23.00
US$575,000 		25,000 +inf% 23.00 US$575,000
2018-07-23 2018-07-20 B Purchase Cuss Francis M Non-Executive Director
10,000 +inf%
23.00
US$230,000 		10,000 +inf% 23.00 US$230,000
Explore more

More insider trading research around Rubius Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America